Viruses creating

An Internet user with the appropriate knowledge can create considerable damage. The I love you computer virus created an estimated 6.7 billion of... 

First synthetic virus created by Eckard Wimmer and associates, based on human poliovirus. 

Synthesis of sandwich-type metal phosphide with two P5 rings Discovered telomeres arranged themselves into 4-stranded G quadruplexes First synthetic virus created... 

Fig. 3 Stepwise development of antiviral resistance. Because of the rapid mutation rate of viruses, the virus population before treatment (a) contains variants, which display by chance a low level of resistance to the drug (indicated by the darker hue). Treatment with suboptimal levels of an antiviral drug (b) creates a bottleneck, which selects for these variants (c). These can further replicate in the presence of the drug and thereby acquire additional mutations, leading to resistant variants with enhanced replicative fitness (d)...

The development of high-magnification microscopy made it possible to create images of biological materials at the molecular level. Many of these images show structures that have liquid crystalline aspects. Shown here are aligned mosaic virus molecules and protein molecules in voluntary muscles. In addition, all cell walls are picket fences of rod-shaped molecules in regular yet fluid arra. ... 

As discussed above, alternative recombinant DNA techniques are necessary to efficiently generate genome-scale clone sets. One alternative exploits the ability of the Vaccinia virus DNA topoisomerase I to both cleave and rejoin DNA strands with high sequence specificity (Shuman, 1992a Shuman, 1992b). In the reaction, the enzyme recognizes the sequence 5 -CCCTT and cleaves at the final T whereby a covalent adduct is formed between the 3 phosphate of the cleaved strand and a tyrosine residue in the enzyme (Fig. 4.1). The covalent complex can combine with a heterologous acceptor DNA that has a 5 hydroxyl tail complementary to the sequence on the covalent adduct to create a recombinant molecule (Shuman, 1994). 

Figure 4.4. Schematic illustration of directional topoisomerase cloning of PCR products into the pUNI vector. The PCR product to be cloned has the sequence 5 -CACC appended at the 5 end to direct the orientation of cloning. The Vaccinia virus topoisomerase I enzyme forms a covalent adduct with the cloning vector to create a cloning competent plasmid construct. The loxP site is 5 to the insertion site. The vector and PCR product are designed to fuse the ORF in-frame with loxP.

Synthetic haptens mimicking some critical epitopic structures on larger macromolecules are often conjugated to carriers to create an immune response to the larger parent molecule. For instance, short peptide segments can be synthesized from the known sequence of a viral coat protein and coupled to a carrier to induce immunogenicity toward the native virus. This type of synthetic approach to immunogen production has become the basis of much of the current research into the creation of vaccines. 

The design of chimeric viruses to create a functional vector system combining components of different viruses and thus expanding the virus host range was one of the early approaches employed by Yusibov et al. [32]. Antigenic determinants from... 

Some diseases caused by viruses are communicable and easily transferred from an infected individual to anyone in close proximity. Typically, this occurs when the infected individual coughs or sneezes creating an infectious aerosol. These aerosols enter the body of a new host through inhalation and /or contact of the aerosol with the mucous membranes of the eyes, nose, or mouth. In addition, although intact skin is an effective barrier against most pathogens, abrasions, or lacerations circumvents this protective barrier and allows entry of the pathogen into the body. 

Whether this remarkable explanation is correct awaits further study, as do many mysteries concerning the ability of virus and wasp to manipulate the hornworms life processes. If the wasp has indeed created the virus for its own purposes, it will be worth considering to what extent the two can be regarded as independent entities. 

The disease known as acquired immune deficiency S5mdrome (AIDS) was first reported in 1981, and the virus that causes it continues to create formidable challenges to the biomedical research and public health communities around the world. Globally, about 14,000 individuals are newly infected daily with one of the nine known subtypes of human immunodeficiency vims (HIV) that cause AIDS. Cumulatively, as of the year 2004, the vims has infected more than 70 million individuals, killing about 30 million and leaving another 40 million with an infection that is ultimately fatal. More than 90% of these infections have occurred in the developing world, where access to antiretroviral therapy is minimal. 

---